保险类型与分化型甲状腺癌手术及辅助治疗适当性相关
基于美国国家癌症数据库2010-2016年224,500例分化型甲状腺癌患者,分析保险状态与治疗适当性及生存的关系。医疗补助和未保险患者接受不适当腺叶切除和放射性碘治疗不足的风险增加,且与生存下降独立相关。医疗补助扩展州与非扩展州在治疗适当性上无差异。
要点
- 医疗补助和未保险患者不适当腺叶切除风险增加(AOR分别为1.36和1.30)。
- 医疗补助和未保险患者放射性碘治疗不足风险增加(AOR分别为1.20和1.44)。
- 不适当腺叶切除和放射性碘治疗不足与生存下降独立相关。
核心结论
- 医疗补助和未保险的分化型甲状腺癌患者接受不适当治疗的风险显著增加,且生存劣于 Medicare 和私人保险患者。
- 医疗补助扩展州与非扩展州在手术或辅助放射性碘治疗的适当性上无差异。
研究设计与样本
- 回顾性队列研究,查询美国国家癌症数据库2010-2016年分化型甲状腺癌患者,共纳入224,500例。
- 计算治疗适当性的调整比值比(AOR)和总生存的风险比(HR),并进行双重差分分析。
主要发现
- 医疗补助患者不适当腺叶切除的AOR为1.36(95%CI 1.21-1.54),未保险患者为1.30(95%CI 1.05-1.60)。
- 医疗补助患者放射性碘治疗不足的AOR为1.20(95%CI 1.14-1.26),未保险患者为1.44(95%CI 1.33-1.55)。
- 不适当腺叶切除与生存下降相关(HR 2.0,95%CI 1.7-2.3,P < .001),放射性碘治疗不足亦相关(HR 2.3,95%CI 2.2-2.5,P < .001)。
- 适当手术切除与生存改善相关(HR 0.3,95%CI 0.3-0.3,P < .001)。
关键数值与推荐
- 治疗适当性依据美国甲状腺协会(ATA)指南定义。
- 医疗补助扩展州与非扩展州在手术或辅助放射性碘治疗的适当性上无差异。
临床怎么用
- 临床应关注医疗补助和未保险的分化型甲状腺癌患者,评估其治疗适当性,避免不适当腺叶切除和放射性碘治疗不足。
- 对低收入患者群体,可考虑针对性干预以改善治疗适当性和生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We aimed to characterize the association between differentiated thyroid cancer (DTC) patient insurance status and appropriateness of therapy (AOT) regarding extent of thyroidectomy and radioactive iodine (RAI) treatment. METHODS: The National Cancer Database was queried for DTC patients diagnosed between 2010 and 2016. Adjusted odds ratios (AOR) for AOT, as defined by the American Thyroid Association guidelines, and hazard ratios (HR) for overall survival (OS) were calculated. A difference-in-differences (DD) analysis examined the association of Medicaid expansion with outcomes for low-income patients aged <65. RESULTS: A total of 224,500 patients were included. Medicaid and uninsured patients were at increased risk of undergoing inappropriate therapy, including inappropriate lobectomy (Medicaid 1.36, 95% confidence interval [CI]: 1.21-1.54; uninsured 1.30, 95% CI: 1.05-1.60), and under-treatment with RAI (Medicaid 1.20, 95% CI: 1.14-1.26; uninsured 1.44, 95% CI: 1.33-1.55). Inappropriate lobectomy (HR 2.0, 95% CI: 1.7-2.3, P < .001) and under-treatment with RAI (HR 2.3, 95% CI: 2.2-2.5, P < .001) were independently associated with decreased survival, while appropriate surgical resection (HR 0.3, 95% CI: 0.3-0.3, P < .001) was associated with improved odds of survival; the model controlled for all relevant clinico-pathologic variables. No difference in AOT was observed in Medicaid expansion versus non-expansion states with respect to surgery or adjuvant RAI therapy. CONCLUSION: Medicaid and uninsured patients are at significantly increased odds of receiving inappropriate treatment for DTC; both groups are at a survival disadvantage compared with Medicare and those privately insured.
引用
- Thiesmeyer JW, Limberg J, Ullmann TM, et al. Insurance type is associated with appropriate use of surgical and adjuvant care for differentiated thyroid carcinoma. Surgery. 2021. PMID: 34600741. doi:10.1016/j.surg.2021.07.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。